Management of candiduria
Candiduria, due to Candida albicans, Candida glabrata and other organisms, has increased in frequency due the use of broad-spectrum antibacterials, immunosuppressive agents and other factors. The optimal management of candiduria is unknown due to an unclear definition of fungal urinary tract infection and the lack of well-designed clinical trials. Removal of urinary catheters, ruling out obstruction/stones and documenting presence of post-void residuals are useful in the management of candiduria. Amphotericin B bladder irrigants and oral fluconazole may be used in certain patients who are high risk or with persistence of candiduria after removal of the urinary catheter.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
1994 |
|---|---|
| Erschienen: |
1994 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
International journal of antimicrobial agents - 4(1994), 2 vom: 08. Juni, Seite 135-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Joseph Guglielmo, B [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 02.10.2012 Date Revised 23.09.2019 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM180756842 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM180756842 | ||
| 003 | DE-627 | ||
| 005 | 20231223160031.0 | ||
| 007 | tu | ||
| 008 | 231223s1994 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0603.xml |
| 035 | |a (DE-627)NLM180756842 | ||
| 035 | |a (NLM)18611602 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Joseph Guglielmo, B |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Management of candiduria |
| 264 | 1 | |c 1994 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 02.10.2012 | ||
| 500 | |a Date Revised 23.09.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Candiduria, due to Candida albicans, Candida glabrata and other organisms, has increased in frequency due the use of broad-spectrum antibacterials, immunosuppressive agents and other factors. The optimal management of candiduria is unknown due to an unclear definition of fungal urinary tract infection and the lack of well-designed clinical trials. Removal of urinary catheters, ruling out obstruction/stones and documenting presence of post-void residuals are useful in the management of candiduria. Amphotericin B bladder irrigants and oral fluconazole may be used in certain patients who are high risk or with persistence of candiduria after removal of the urinary catheter | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Stoller, M L |e verfasserin |4 aut | |
| 700 | 1 | |a Jabos, R A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of antimicrobial agents |d 1991 |g 4(1994), 2 vom: 08. Juni, Seite 135-9 |w (DE-627)NLM090678974 |x 1872-7913 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:1994 |g number:2 |g day:08 |g month:06 |g pages:135-9 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 1994 |e 2 |b 08 |c 06 |h 135-9 | ||